| dc.contributor.author |
Grözinger, Gerd |
|
| dc.date.accessioned |
2026-01-14T09:49:53Z |
|
| dc.date.available |
2026-01-14T09:49:53Z |
|
| dc.date.issued |
2025 |
|
| dc.identifier.issn |
1479-6694 |
|
| dc.identifier.uri |
http://hdl.handle.net/10900/173927 |
|
| dc.language.iso |
en |
de_DE |
| dc.publisher |
Abingdon : Taylor & Francis Ltd |
de_DE |
| dc.relation.uri |
http://dx.doi.org/10.1080/14796694.2024.2446137 |
de_DE |
| dc.subject.ddc |
610 |
de_DE |
| dc.title |
BioPearl™ doxorubicin microspheres for unresectable HCC : a prospective, single-arm, multicenter study : BIOPEARL-ONE |
de_DE |
| dc.type |
Article |
de_DE |
| utue.quellen.id |
20250630000000_02239 |
|
| utue.publikation.seiten |
557-564 |
de_DE |
| utue.personen.roh |
Verset, Gontran |
|
| utue.personen.roh |
Iezzi, Roberto |
|
| utue.personen.roh |
Bargellini, Irene |
|
| utue.personen.roh |
Bucalau, Ana-Maria |
|
| utue.personen.roh |
Pereira, Philippe |
|
| utue.personen.roh |
Grözinger, Gerd |
|
| utue.personen.roh |
Spreafico, Carlo |
|
| utue.personen.roh |
Maleux, Geert |
|
| dcterms.isPartOf.ZSTitelID |
Future Oncology |
de_DE |
| dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
| dcterms.isPartOf.ZS-Volume |
21 |
de_DE |
| utue.fakultaet |
04 Medizinische Fakultät |
de_DE |